Avidity Partners Management’s Dynavax Technologies DVAX Stock Holding History

Avidity Partners Management’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,400,000	Closed	-$33.5M	–	116
2021 Q2	$33.5M	Sell	3,400,000 -100,000	-3%	-$909K	0.91%	40
2021 Q1	$34.4M	Sell	3,500,000 -500,000	-13%	-$4.12M	0.95%	39
2020 Q4	$17.8M	Buy	4,000,000 +1,975,000	+98%	+$8.94M	0.58%	51
2020 Q3	$8.75M	Sell	2,025,000 -649,154	-24%	-$4.63M	0.41%	48
2020 Q2	$23.7M	Sell	2,674,154 -1,149,846	-30%	-$5.81M	1.52%	23
2020 Q1	$13.5M	Buy	3,824,000 +3,044,000	+390%	+$14.1M	1.87%	22
2019 Q4	$4.46M	Buy	+780,000	New	+$4.17M	2.81%	16

Other funds holding DVAX

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Avidity Partners Management's DVAX Position: Q3 2021 in Review

Avidity Partners Management sold out of Dynavax Technologies (DVAX) in Q3 2021, closing a stake of 3,400,000 shares — an estimated $33.5M sold.

Avidity Partners Management first reported a position in DVAX in Q4 2019 and held it in 7 quarters. The position peaked at $34.4M in Q1 2021. 183 funds tracked by Wall St. Rank hold DVAX as of Q3 2021.

Avidity Partners Management reported no remaining Dynavax Technologies position as of Q3 2021 after selling out during the quarter.
Avidity Partners Management sold 3,400,000 Dynavax Technologies shares in Q3 2021, an estimated $33.5M.
Avidity Partners Management first reported a position in Dynavax Technologies in Q4 2019 and held it in 7 quarters.
Avidity Partners Management's Dynavax Technologies position peaked at $34.4M in Q1 2021.
183 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2021.

Based on Avidity Partners Management's 13F filing for Q3 2021, filed 15 Nov 2021.